P3 Health Partners Inc.
PIII
$6.35
-$0.07-1.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.68% | 2.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.68% | 2.36% | |||
| Cost of Revenue | -9.31% | 2.07% | |||
| Gross Profit | 102.99% | 0.65% | |||
| SG&A Expenses | -20.88% | -5.14% | |||
| Depreciation & Amortization | -0.48% | -2.40% | |||
| Other Operating Expenses | -118.36% | 108.76% | |||
| Total Operating Expenses | -17.92% | 5.43% | |||
| Operating Income | 70.80% | -15.24% | |||
| Income Before Tax | 65.24% | -16.67% | |||
| Income Tax Expenses | -78.33% | 237.36% | |||
| Earnings from Continuing Operations | 65.74% | -25.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -66.30% | 25.19% | |||
| Net Income | 65.06% | -26.03% | |||
| EBIT | 70.80% | -15.24% | |||
| EBITDA | 84.41% | -19.42% | |||
| EPS Basic | 75.01% | -74.99% | |||
| Normalized Basic EPS | 77.76% | -2.12% | |||
| EPS Diluted | 78.37% | -85.02% | |||
| Normalized Diluted EPS | 77.76% | -3.89% | |||
| Average Basic Shares Outstanding | 39.81% | -27.98% | |||
| Average Diluted Shares Outstanding | 39.81% | -29.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||